Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 3,659 | 3,743 | 3,654 | 3,488 | 4,295 |
| Gross Profit | 3,659 | 3,743 | 3,654 | 3,488 | 4,295 |
| Operating Expenses | 4,829 | 6,144 | 8,722 | 6,687 | 5,777 |
| Operating Income | -1,170 | -2,402 | -5,068 | -3,199 | -1,482 |
| Interest Expense | 57 | 70 | 78 | 90 | 100 |
| Other Income | 781 | 243 | 733 | -628 | 357 |
| Pre-tax Income | -446 | -2,229 | -4,413 | -3,917 | -1,225 |
| Income Tax | -7 | 30 | 12 | 29 | 11 |
| Net Income Continuous | -439 | -2,258 | -4,425 | -3,946 | -1,236 |
| Net Income | $-439 | $-2,258 | $-4,425 | $-3,946 | $-1,236 |
| EPS Basic Total Ops | -3.00 | -12.01 | -27.03 | -24.02 | -6.01 |
| EPS Basic Continuous Ops | -2.41 | -12.79 | -26.18 | -22.71 | -7.46 |
| EPS Diluted Total Ops | -3.00 | -12.01 | -27.03 | -24.02 | -6.01 |
| EPS Diluted Continuous Ops | -2.41 | -12.79 | -26.18 | -22.71 | -7.46 |
| EBITDA(a) | $-1,134 | $-2,362 | $-5,024 | $-3,155 | $-1,440 |